Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Karyopharm Therapeutics (KPTI) Change in Acquisitions & Divestments (2016 - 2025)

Karyopharm Therapeutics (KPTI) has disclosed Change in Acquisitions & Divestments for 11 consecutive years, with $5.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Acquisitions & Divestments fell 69.23% year-over-year to $5.0 million, compared with a TTM value of $43.4 million through Dec 2025, down 71.91%, and an annual FY2025 reading of $43.4 million, down 71.91% over the prior year.
  • Change in Acquisitions & Divestments was $5.0 million for Q4 2025 at Karyopharm Therapeutics, up from $4.8 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $69.0 million in Q1 2021 and bottomed at $4.8 million in Q3 2025.
  • Average Change in Acquisitions & Divestments over 5 years is $34.0 million, with a median of $31.1 million recorded in 2021.
  • The sharpest move saw Change in Acquisitions & Divestments skyrocketed 113.38% in 2023, then plummeted 83.01% in 2025.
  • Year by year, Change in Acquisitions & Divestments stood at $30.5 million in 2021, then grew by 4.34% to $31.8 million in 2022, then skyrocketed by 36.49% to $43.4 million in 2023, then tumbled by 62.56% to $16.2 million in 2024, then crashed by 69.23% to $5.0 million in 2025.
  • Business Quant data shows Change in Acquisitions & Divestments for KPTI at $5.0 million in Q4 2025, $4.8 million in Q3 2025, and $18.3 million in Q2 2025.